Both Semaglutide and Semaglutide belong to a group of therapies called Glucagon-like Peptide-1 receptor for agonists . These innovative treatments operate by imitating the body's own hormone , Glucagon-like Peptide-1, to support lower sugar in the blood and promote weight reduction . This shared mechanism of effect highlights why they drugs are com